MPG.eBooks - Description: Clinical review report: Cysteamine delayed-release capsules (Procysbi) Horizon Pharma Ireland Ltd

Read Now

The objective of this review is to perform a systematic review of the beneficial and harmful effects of delayed-release cysteamine (Procysbi [RP103])

Bibliographic Details
Corporate Author:	Canadian Agency for Drugs and Technologies in Health
Format:	eBook
Language:	English
Published:	Ottawa (ON) Canadian Agency for Drugs and Technologies in Health 2018, February 2018
Edition:	Version: final
Series:	CADTH common drug review
Subjects:	Canada Cystine Depleting Agents Cysteamine / Therapeutic Use Cystinosis / Drug Therapy Delayed-action Preparations
Online Access:	https://www.ncbi.nlm.nih.gov/books/NBK534005
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa

Description
Summary:	The objective of this review is to perform a systematic review of the beneficial and harmful effects of delayed-release cysteamine (Procysbi [RP103])
Item Description:	"Indication: For the treatment of nephropathic cystinosis."
Physical Description:	1 PDF file (67 pages) illustrations